Baxter International Inc. (BAX)

NYSE: BAX · Real-Time Price · USD
29.50
+0.60 (2.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
2.08%
Market Cap 15.06B
Revenue (ttm) 15.06B
Net Income (ttm) 108.00M
Shares Out 510.59M
EPS (ttm) 0.21
PE Ratio 123.91
Forward PE 12.85
Dividend $1.04 (3.53%)
Ex-Dividend Date Nov 29, 2024
Volume 11,320,591
Open 29.34
Previous Close 28.90
Day's Range 29.17 - 29.99
52-Week Range 28.62 - 44.01
Beta 0.57
Analysts Hold
Price Target 40.90 (+38.64%)
Earnings Date Feb 6, 2025

About BAX

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technol... [Read more]

Sector Healthcare
Founded 1931
Employees 60,000
Stock Exchange NYSE
Ticker Symbol BAX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for BAX stock is "Hold." The 12-month stock price forecast is $40.9, which is an increase of 38.64% from the latest price.

Price Target
$40.9
(38.64% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Jo...

2 days ago - Business Wire

Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product laun...

10 days ago - Business Wire

Baxter resumes dialysis solution production at its hurricane-hit facility

Baxter International said on Thursday it has resumed production on all dialysis solution manufacturing lines at its North Carolina facility after they were impacted by hurricane-related flooding.

15 days ago - Reuters

Baxter to Present at 7th Annual Evercore HealthCONx Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 7th Annual Evercore HealthCONx Conference on Thursday, December 5, 2024. Joel Grade...

4 weeks ago - Business Wire

Baxter to Present at Jefferies London Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade,...

5 weeks ago - Business Wire

Baxter to Present at Stifel 2024 Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxter'...

5 weeks ago - Business Wire

Baxter Declares Quarterly Dividend

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o...

5 weeks ago - Business Wire

Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript

Baxter International Inc. (NYSE:BAX) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Joe Al...

6 weeks ago - Seeking Alpha

Baxter cuts annual profit forecast on hurricane impact

Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.

6 weeks ago - Reuters

Baxter Reports Third-Quarter 2024 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2024. “Baxter delivered positive performance in the thi...

6 weeks ago - Business Wire

Baxter restarts IV solutions manufacturing line

Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related fl...

7 weeks ago - Reuters

Oneview Healthcare and Baxter International Extend Value-Added Reseller Agreement for Two More Years and Expand the Agreement to include Canada

DUBLIN--(BUSINESS WIRE)--Oneview Healthcare, a leading provider of patient experience solutions is pleased to announce the extension of its strategic relationship with Baxter International Inc. for an...

7 weeks ago - Business Wire

Baxter expects to restart IV solutions manufacturing line within next week

Medical device maker Baxter said on Thursday it expects to restart the highest-throughput IV solutions manufacturing line at a hurricane-hit plant in North Carolina within the next week.

2 months ago - Reuters

Baxter to Present at UBS Global Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Joel Grade, Baxte...

2 months ago - Business Wire

Baxter aims to restore new dialysis patient access to pre-hurricane levels by year-end

Baxter International on Monday said that it aims to restore the number of new patients able to begin using its peritoneal dialysis solutions to pre-Hurricane Helene levels by the end of the year.

2 months ago - Reuters

Baxter to import 18,000 tons of IV products to US by year-end

Baxter International said on Thursday it will import 18,000 tons of intravenous products from its newly cleared international plants to the U.S. by the end of the year to mitigate a shortage caused by...

2 months ago - Reuters

Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8, ...

2 months ago - Business Wire

Baxter Is A Strong Buy: The Turnaround Story You Can't Ignore

The Federal Reserve's rate cut historically boosts healthcare stocks, and Baxter International's recent downturn presents a buying opportunity due to overblown market reactions. Baxter's acquisition o...

2 months ago - Seeking Alpha

Baxter International (BAX) Reports Impact of Hurricane Helene on North Cove Facility

Baxter International Inc. (BAX, Financial), a leading healthcare company, has issued a press release detailing the impact of Hurricane Helene on its North Cove facility located in Marion, North Caroli...

2 months ago - GuruFocus

Does Baxter Stock Offer Any Room For Growth?

Baxter stock (NYSE: BAX), a healthcare company, currently trades at $38 per share, more than 50% lower than the level seen in February 2022. BAX stock has fared worse than its peer – Becton, Dickinson...

2 months ago - Forbes

Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina

Baxter International Inc BAX. has shut down its largest manufacturing facility following significant damage caused by Hurricane Helene.

2 months ago - Benzinga

Baxter Provides Update on North Cove, N.C., Facility and Hurricane Helene Relief Plans for Community

DEERFIELD, Ill.--(BUSINESS WIRE)---- $BAX--Baxter International Inc. (NYSE:BAX), a global medtech leader, today shared updates regarding the impact of Hurricane Helene, which brought unprecedented rai...

2 months ago - Business Wire

Baxter Launches Next Generation of The Vest System for Airway Clearance

BOSTON--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, today unveiled its next generation airway clearance system, The Vest Advanced Pulmonary Experience (APX...

3 months ago - Business Wire

5 Incredible Healthcare High-Yield Blue-Chip Bargain Buys For 2025

Healthcare is undervalued despite being the top sector for earnings growth, making it an attractive investment with solid fundamentals and the potential for explosive returns in 2025. Investing in hea...

Other symbols: BMYCVSHUMPFE
3 months ago - Seeking Alpha

Broyhill's Q2 2024 Top Five Investments

Our top five investments—Avantor, Baxter, Fiserv, Nintendo, and Philip Morris—represented 50% of the equity portfolio, with mixed performance during the quarter. Avantor's shares rallied 26% in July a...

Other symbols: AVTRFIPM
3 months ago - Seeking Alpha